Novartis Investigative Site — Berlin

Public research footprint of Novartis Investigative Site, compiled from the ClinicalTrials.gov public registry.

575

Registered studies

Active

Recruiting now

420

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and… · Early Breast Cancer · Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) · Neovascular Age-related Macular Degeneration (nAMD)

Recently updated registry entries

NCT05939414 — An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation… (Recruiting)
NCT07217067 — A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605… (Recruiting)
NCT05268289 — Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Novartis Investigative Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.